Pfizer's New Global Capability Centre Enhances Commercial Analytics in India
Pfizer's New Initiative in Commercial Analytics
NEW DELHI: Pfizer Inc has officially launched its first-ever dedicated commercial analytics centre in India, known as the 'Analytics Gateway'. This facility represents the company's first Global Capability Centre (GCC) serving international markets outside the U.S.
The centre is strategically located in Mumbai to facilitate analytics and insight breakthroughs that will benefit patients globally. As stated by the company, this initiative is a milestone in Pfizer's international commercial strategy, driving growth across 140 international markets while utilizing advanced data analytics, artificial intelligence, and crucial insights.
Importance of the Analytics Gateway
- Represents a significant shift in Pfizer's approach to international operations.
- India is expected to play a pivotal role in the company's growth with GCCs.
- The analytics solutions from this centre are aimed at modernizing marketing efforts and creating an agile sales force.
According to Meenakshi Nevatia, country president of Pfizer India, “The actionable insights generated by the Analytics Gateway will power up our global commercial engine and modernize healthcare to meet the evolving needs of patients in India and worldwide.” This move not only exemplifies Pfizer's commitment to innovation in healthcare but also positions India as a hub for global business analytics.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.